Is ARNI or GBDC a better dividend investment in 2026?

ARNI currently yields 1000000.00% with a 5% 5-year dividend growth rate. GBDC yields 11.86% with 5% growth. The better choice depends on your goal: ARNI offers higher current income.

What is the dividend yield difference between ARNI and GBDC?

ARNI has a forward dividend yield of 1000000.00% ($2.00/share annually). GBDC yields 11.86% ($1.50/share annually). The yield gap is 999988.14 percentage points.

Home › Compare › ARNI vs GBDC

ARNI vs GBDC: Dividend Comparison 2026

ARNI yields 1000000.00% · GBDC yields 11.86%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 ARNI wins by $4.7683925249533696e+36M in total portfolio value

INVESTMENT

TIME HORIZON10 years

ARNI

● Live price

1000000.00%

Share price

$0.00

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$4.7683925249533696e+36M

Annual income

$4,767,454,694,456,067,000,000,000,000,000,000,000,000,000.00

Full ARNI calculator →

GBDC

● Live price

11.86%

Share price

$12.65

Annual div

$1.50

5Y div CAGR

51.1%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$20.85M

Annual income

$16,450,733.83

Full GBDC calculator →

Portfolio growth — ARNI vs GBDC

📍 ARNI pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	ARNI	GBDC
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, ARNI + GBDC cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

ARNI pays

GBDC pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ARNI

Annual income on $10K today (after 15% tax)

$85,000,000.00/yr

After 10yr DRIP, annual income (after tax)

$4,052,336,490,287,657,000,000,000,000,000,000,000,000,000.00/yr

GBDC

Annual income on $10K today (after 15% tax)

$1,007.91/yr

After 10yr DRIP, annual income (after tax)

$13,983,123.76/yr

At 15% tax rate, ARNI beats the other by $4,052,336,490,287,657,000,000,000,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ARNI + GBDC for your $10,000?

ARNI: 50%GBDC: 50%

100% GBDC50/50100% ARNI

Portfolio after 10yr

$2.3841962624766848e+36M

Annual income

$2,383,727,347,228,033,600,000,000,000,000,000,000,000,000.00/yr

Blended yield

99.98%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on GBDC right now

ARNI

No analyst data

Altman Z

-76.9

Piotroski

2/9

GBDC

Analyst Ratings

Buy

Hold

Consensus: Buy

Price Target

$14.00

+10.7% upside vs current

Range: $13.00 — $15.00

Altman Z

0.6

Piotroski

6/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ARNI buys

GBDC buys

No recent congressional trades found for ARNI or GBDC in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricARNIGBDC

Forward yield	1000000.00% ✓	11.86%
Annual dividend / share	$2.00 ✓	$1.50
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	51.1% ✓
Portfolio after 10y	$4.7683925249533696e+36M	$20.85M ✓
Annual income after 10y	$4,767,454,694,456,067,000,000,000,000,000,000,000,000,000.00 ✓	$16,450,733.83
Total dividends collected	$4.7683311610149396e+36M	$20.43M ✓
Payment frequency	quarterly	quarterly
Sector	Stock	BDC

Year-by-year: ARNI vs GBDC ($10,000, DRIP)

Year	ARNI Portfolio	ARNI Income/yr	GBDC Portfolio	GBDC Income/yr	Gap
1← crossover	$100,010,700	$100,000,000.00	$12,492	$1,791.70	+$100.00M → ARNI
2	$934,786,450,701	$934,679,439,252.34	$16,527	$3,160.58	+$934786.43M → ARNI
3	$8,165,787,108,578,292	$8,164,786,887,076,042.00	$23,588	$5,904.90	+$8165787108.55M → ARNI
4	$66,665,884,190,957,650,000	$66,657,146,798,751,470,000.00	$37,141	$11,901.65	+$66665884190957.61M → ARNI
5	$508,662,171,058,048,100,000,000	$508,590,838,561,963,700,000,000.00	$66,205	$26,463.38	+$508662171058048128.00M → ARNI
6	$3,627,235,248,428,489,700,000,000,000	$3,626,690,979,905,457,600,000,000,000.00	$137,452	$66,612.65	+$3.62723524842849e+21M → ARNI
7	$24,173,681,159,150,610,000,000,000,000,000	$24,169,800,017,434,790,000,000,000,000,000.00	$342,372	$195,298.53	+$2.417368115915061e+25M → ARNI
8	$150,567,402,861,454,640,000,000,000,000,000,000	$150,541,537,022,614,370,000,000,000,000,000,000.00	$1,053,292	$686,954.33	+$1.5056740286145463e+29M → ARNI
9	$876,477,100,281,847,600,000,000,000,000,000,000,000	$876,315,993,160,785,800,000,000,000,000,000,000,000.00	$4,111,439	$2,984,416.95	+$8.764771002818475e+32M → ARNI
10	$4,768,392,524,953,369,600,000,000,000,000,000,000,000,000	$4,767,454,694,456,067,000,000,000,000,000,000,000,000,000.00	$20,849,974	$16,450,733.83	+$4.7683925249533696e+36M → ARNI

ARNI vs GBDC: Complete Analysis 2026

ARNI — Stock

Arno Therapeutics, Inc., a biopharmaceutical company, develops products for the treatment of cancer and other life threatening diseases. The company's product development pipeline includes Onapristone, a type 1 anti-progestin hormone blocker that is in Phase I/II clinical study for the treatment of breast, endometrial, and others solid tumors in post-menopausal women; and advanced castration-resistant prostate cancer in men. Its product development pipeline also consists of AR-12, an orally available cancer treatment, which has completed Phase I clinical study for the treatment of solid tumors and hematological malignancies, as well as in Pre-clinical studies for the treatment of various anti-microbial targets. In addition, the company's product development pipeline comprises AR-42, a novel orally available cancer therapy that is in Phase I investigator-initiated clinical study for the treatment of hematological malignancies and solid tumors. The company has license agreements with Invivis Pharmaceuticals, Inc.; the Regents of the University of Minnesota; and the Ohio State University Innovation Foundation, as well as a co-development agreement with Leica Biosystems Newcastle Ltd. Arno Therapeutics, Inc. is based in Flemington, New Jersey.

Full ARNI Calculator →

GBDC — BDC

Golub Capital BDC, Inc. (GBDC) is a business development company and operates as an externally managed closed-end non-diversified management investment company. It invests in debt and minority equity investments in middle-market companies that are, in most cases, sponsored by private equity investors. It typically invests in diversified consumer services, automobiles, healthcare technology, insurance, health care equipment and supplies, hotels, restaurants and leisure, healthcare providers and services, IT services and specialty retails. It seeks to invest in the United States. It primarily invests in first lien traditional senior debt, first lien one stop, junior debt and equity, senior secured, one stop, unitranche, second lien, subordinated and mezzanine loans of middle-market companies, and warrants.

Full GBDC Calculator →

📬

Get this ARNI vs GBDC comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ARNI vs SCHD ARNI vs JEPI ARNI vs O ARNI vs KO ARNI vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.